www.fdanews.com/articles/185075-xcision-medical-system-breast-cancer-radiotherapy-technology-scores-fda-clearance
Xcision Medical System Breast Cancer Radiotherapy Technology Scores FDA Clearance
January 3, 2018
Maryland-based Xcision Medical Systems achieved FDA 510(k) clearance for its noninvasive stereotactic radiation therapy system indicated for breast cancer treatment.
The GammaPod system features thousands of focused radiation beams and a vacuum-assisted cup for immobilizing the breast during a treatment procedure to preserve healthy tissue around the tumor.
About 60 percent of all cancer patients receive some form of radiotherapy.